IRLAB (Q2 Review): Partnering remains in focus - Redeye
Redeye return with an update after IRLAB's Q2 report, which contained few surprises. We reiterate our fundamental DCF valuation and introduce our new fair value. IRLAB screens "attractively priced".
ANNONS
Redeye return with an update after IRLAB's Q2 report, which contained few surprises. We reiterate our fundamental DCF valuation and introduce our new fair value. IRLAB screens "attractively priced".
